Paris—Dentons advised Essling Expansion on the capital reorganisation of the Teknimed Group around its director and shareholder, Carole Léonard, Essling Expansion becoming its majority shareholder alongside two co-investors: Multicroissance and Bourrelier Group. The financing of the unitranche debt is provided by Apera Asset Management, a European private debt fund.

Essling Expansion is a fund investing in high-growth companies in the digital, healthcare and B2B services sectors. It is managed by Essling Capital, an independent asset management company specialising in unlisted assets (€450M of assets under management).

Based in Toulouse, Teknimed is a leading player in the implantable biomaterials market, particularly in the manufacture and development of bone cements in France for 30 years. With more than 80% of its turnover generated internationally, the Group stands out thanks to products whose quality is unanimously recognised, a modern production tool, a capacity for innovation and regulatory know-how at the highest standards.

This reorganisation will allow Teknimed to increase its organic growth, which has so far been around 10% per year, by maintaining innovation at the heart of its project and by accelerating in certain geographies, such as North America, including through OEM type contracts. To achieve this, the shareholders intend to implement an ambitious Buy & Build strategy that will also allow the integration of disruptive or complementary technologies.

The multidisciplinary team was composed of Olivia Guéguen (partner) Pierre-Marie Gallo and Frédéric Long (associates) for M&A aspects, Jean-Marc Allix (partner) et Steeve Jaskierowicz (associate) for financing aspects, Jérôme Le Berre (counsel) and Paul Hulot (associate) for tax aspects, Nathaly Blin (counsel) for labor aspects, Loïc Lemercier (partner) and Tom Blanchet (associate) IP aspects.

About Dentons

Redefining possibilities. Together, everywhere. For more information visit dentons.com